Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Alpine Immune Sciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 47 | 1 | 44 | −2 |
| Shares | 13.2M | 12.0K | 15.3M | +2.17M (+16.5%) |
| Value | $118.5M | $108.0K | $163.5M | +$45.1M (+38.1%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BVF Inc | 1,589,495 | $17.0M | 0.66% |
| Logos Global Management LP | 425,000 | $4.54M | 0.33% |
| HighVista Strategies LLC | 14,268 | $152.0K | 0.10% |
| UBS Group AG | 1,142 | $12.0K | 0.00% |
Sold out (6)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Ikarian Capital, LLC | 300,454 | $2.70M |
| Samsara BioCapital, LLC | 275,169 | $2.48M |
| Acadian Asset Management LLC | 67,156 | $604.0K |
| Boothbay Fund Management, LLC | 35,523 | $320.0K |
| Hancock Whitney Corp | 18,721 | $168.0K |
| STRS Ohio | 2,700 | $24.0K |
Not filed for Q3 2021 yet (1)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Western Wealth Management, LLC | 12,000 | $108.0K |